BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
-19.01%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$911M
AUM Growth
-$333M
(-27%)
Cap. Flow
-$42.3M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
87.82%
Holding
27
New
1
Increased
6
Reduced
4
Closed
2
Top Buys
| 1 |
Disc Medicine
IRON
|
+$21.6M |
| 2 |
Century Therapeutics
IPSC
|
+$13.8M |
| 3 |
Kyverna Therapeutics
KYTX
|
+$1.53M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$1.02M |
| 5 |
Xilio Therapeutics
XLO
|
+$929K |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$52.6M |
| 2 |
Nurix Therapeutics
NRIX
|
+$16.6M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
+$9.12M |
| 4 |
Aclaris Therapeutics
ACRS
|
+$2.2M |
| 5 |
Annexon
ANNX
|
+$1.24M |
Sector Composition
| 1 | Healthcare | 99.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Nurix Therapeutics
NRIX
$691M
| – | – |
-1,132,397
| Closed | -$16.6M |
|
|
27
Madrigal Pharmaceuticals
MDGL
$9.63B
| – | – |
-196,995
| Closed | -$52.6M |
|